デフォルト表紙
市場調査レポート
商品コード
958072

乳児臨床栄養の世界市場

Infant Clinical Nutrition

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.03円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

乳児臨床栄養の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の乳児臨床栄養の市場規模は、分析期間(2020年~2027年)に4.9%のCAGRで成長する見通しで、2020年の197億米ドルから2027年には274億米ドルに達すると予測されています。当レポートで分析されているセグメントの1つであるミルクベースは、分析期間中に4.7%の年率で成長し、165億米ドルに達すると予測されています。

当レポートは、世界の乳児臨床栄養市場について調査しており、市場シェア、動向や見通し、成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Claris Lifesciences Ltd.
  • Fresenius Kabi AG
  • Groupe Danone
  • Mead Johnson Nutrition Company
  • Meiji Co., Ltd.
  • Nestle Health Science SA
  • Nutricia North America

目次

I. イントロダクション、調査手法、調査範囲

II. エグゼクティブサマリー

  • 市場概要
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と成長要因
  • 世界市場の見通し

III. 市場分析

  • 地域別市場分析
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • プロファイルされた企業の総数:46社
目次
Product Code: MCP12702

Abstract:

Global Infant Clinical Nutrition Market to Reach $27.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Infant Clinical Nutrition estimated at US$19.7 Billion in the year 2020, is projected to reach a revised size of US$27.4 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Milk Based, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$16.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Soy-Based segment is readjusted to a revised 5.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $5.8 Billion, While China is Forecast to Grow at 4.6% CAGR

The Infant Clinical Nutrition market in the U.S. is estimated at US$5.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Organic Segment to Record 5.7% CAGR

In the global Organic segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$2.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.2 Billion by the year 2027.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Claris Lifesciences Ltd.
  • Fresenius Kabi AG
  • Groupe Danone
  • Mead Johnson Nutrition Company
  • Meiji Co., Ltd.
  • Nestle Health Science SA
  • Nutricia North America

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Infant Clinical Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Infant Clinical Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Infant Clinical Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Milk Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Milk Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Milk Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Soy-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Soy-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Soy-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Organic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Organic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Organic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Probiotic/Prebiotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Probiotic/Prebiotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Probiotic/Prebiotic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Enteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Enteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Enteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Intravenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Intravenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Intravenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 31: Canada Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 34: Canada Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 40: Japan Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 43: China Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 46: China Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 49: Europe Current & Future Analysis for Infant Clinical Nutrition by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Infant Clinical Nutrition by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Infant Clinical Nutrition by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 58: France Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 64: Germany Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 70: Italy Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 76: UK Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Rest of Europe Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Rest of Europe 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 85: Rest of Europe Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Europe Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Rest of Europe 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 88: Asia-Pacific Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Asia-Pacific Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Asia-Pacific 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 91: Asia-Pacific Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Asia-Pacific Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Asia-Pacific 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 94: Rest of World Current & Future Analysis for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of World Historic Review for Infant Clinical Nutrition by Product - Milk Based, Soy-Based, Organic and Probiotic/Prebiotic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of World 15-Year Perspective for Infant Clinical Nutrition by Product - Percentage Breakdown of Value Sales for Milk Based, Soy-Based, Organic and Probiotic/Prebiotic for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of World Current & Future Analysis for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of World Historic Review for Infant Clinical Nutrition by Route Of Administration - Oral, Enteral and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of World 15-Year Perspective for Infant Clinical Nutrition by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Enteral and Intravenous for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46